UNI-EN 16:Sopharma AD acquired 51% of RAP Pharma International
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 16 | / | 2017 | |||||||
| Date of issue: | 2017-04-18 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma AD acquired 51% of RAP Pharma International | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD notifies that after receiving a permission from the Moldova Competition Commission, Sopharma AD acquired 51% of the Moldova pharmaceutical distributor RAP Pharma International. RAP PHARMA INTERNATIONAL (RAP) was established in 2004 and in 2014 started its activities in the pharmaceutical sector after receiving a license for pharmaceutical wholesaling and distribution. Currently the company owns 10 pharmacies and is the most intensively developing company in the Republic of Moldova. The revenues of the company for 2016 increased with almost 40% to 3 million EUR. The company has 79 employees and is one of the 7 distributors in Moldova owning a pharmacies network. The retail market in Moldova for 2016 according to Pharmexpert is about 100 million EUR (a precise statistics is not available). Currently the company is a distributor of the products of Sopharma AD, Medica AD, Momina krepost AD, STADA, GRINDEX - Baltics, POLPHARMA, LEKPHARM - Belarus, FARMA PRIM - Moldova, FLUMED FARM - Moldova, BALKAN PHARMACEUTICALS - Moldova etc.. Since 2016 RAP Pharma is added in the list of companies supplying medicinal products to the State Hospitals in the Republic of Moldova through a centralized tender. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Notification_Moldova.doc Notification_Moldova.doc | Sopharma AD acquired 51% of RAP Pharma International | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-04-18 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 6.61 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
